HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshitaka Tanaka Selected Research

Radial Neuropathy (Saturday Night Palsy)

4/2022Outcomes of Rerouting the Palmaris Longus to Extensor Pollicis Longus Tendon Transfer through the Second Extensor Compartment for Radial Nerve Palsy.
9/2020Effectiveness of ultrasonographic evaluation under general anesthesia for radial nerve palsy associated with humeral fractures during the first operation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshitaka Tanaka Research Topics

Disease

5Neoplasms (Cancer)
01/2021 - 01/2010
3Glioblastoma (Glioblastoma Multiforme)
01/2019 - 01/2016
3Inflammation (Inflammations)
05/2010 - 04/2006
3Dermatitis
06/2009 - 01/2005
2Radial Neuropathy (Saturday Night Palsy)
04/2022 - 09/2020
2Infections
01/2022 - 11/2010
2Glossopharyngeal Nerve Diseases (Glossopharyngeal Neuralgia)
01/2016 - 01/2016
2Pain (Aches)
01/2016 - 06/2012
2Bone Resorption
01/2016 - 12/2015
2Experimental Melanoma
05/2011 - 06/2009
2Multiple Myeloma
12/2010 - 06/2009
2Edema (Dropsy)
06/2009 - 04/2006
1Traumatic Amputation (Traumatic Amputations)
12/2020
1Humeral Fractures
09/2020
1Glioma (Gliomas)
03/2019
1Brain Neoplasms (Brain Tumor)
03/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2019
1Vascular Diseases (Vascular Disease)
12/2018
1Necrosis
01/2016
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2016
1Aneurysm (Aneurysms)
01/2016
1Postmenopausal Osteoporosis
12/2015
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
05/2015
1Hemangioblastoma
05/2015
1Lung Neoplasms (Lung Cancer)
05/2013
1Peripheral Nerve Injuries
06/2012
1Hypersensitivity (Allergy)
06/2012
1Cerebral Infarction
01/2012
1Stroke (Strokes)
07/2011
1Brain Ischemia (Cerebral Ischemia)
07/2011
1Ischemic Stroke
07/2011
1Hypopigmentation (Hypomelanosis)
05/2011
1Hyperplasia
05/2010
1Psoriasis (Pustulosis Palmaris et Plantaris)
05/2010
1Intracranial Aneurysm (Cerebral Aneurysm)
01/2010
1Cushing Syndrome
01/2010
1Hepatitis
10/2009

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
03/2019 - 03/2003
4CytokinesIBA
10/2009 - 04/2003
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2009 - 03/2005
3Pharmaceutical PreparationsIBA
01/2022 - 10/2009
3Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
05/2010 - 06/2009
2Monophenol Monooxygenase (Tyrosinase)IBA
05/2011 - 06/2009
2AntigensIBA
12/2010 - 01/2005
21- cyclohexyl- N- (6- (4- hydroxy- 1- piperidinyl)- 3- pyridinyl)- 3- methyl- 1H- thieno(2,3- c)pyrazole- 5- carboxamideIBA
05/2010 - 06/2009
2Interleukin-4 (Interleukin 4)IBA
10/2009 - 10/2004
2Phorbol EstersIBA
06/2009 - 04/2006
1Butyric Acid (Butanoic Acid)IBA
01/2022
1Cytochrome P-450 CYP3AIBA
01/2022
1EnzymesIBA
01/2022
1Trastuzumab (Herceptin)FDA Link
01/2021
1cixutumumabIBA
01/2021
1Immunoglobulin Fab FragmentsIBA
01/2021
1protoporphyrin IXIBA
03/2019
1AcidsIBA
03/2019
1Peptides (Polypeptides)IBA
03/2019
1Temozolomide (Temodar)FDA LinkGeneric
01/2019
1GalactosidasesIBA
01/2019
1LigandsIBA
01/2019
1ErbB Receptors (EGF Receptor)IBA
09/2018
1Chimeric Antigen ReceptorsIBA
09/2018
1epidermal growth factor receptor VIIIIBA
09/2018
1Carbamazepine (Tegretol)FDA LinkGeneric
01/2016
1NitrogenIBA
01/2016
1Thomsen-Friedenreich antibodiesIBA
01/2016
1Orexin Receptor AntagonistsIBA
01/2016
1Diphosphonates (Bisphosphonates)IBA
01/2016
1suvorexantIBA
01/2016
1Granzymes (Granzyme)IBA
01/2016
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2016
1YM 529IBA
01/2016
1Mevalonic Acid (Mevalonate)IBA
01/2016
1SI-591IBA
12/2015
1CalciumIBA
12/2015
1Cathepsin KIBA
12/2015
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
05/2015
1Phosphotransferases (Kinase)IBA
05/2013
1Gefitinib (Iressa)FDA Link
05/2013
1((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA
05/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
05/2013
1Adenosine Triphosphate (ATP)IBA
06/2012
12-decenoic acidIBA
01/2012
1EstersIBA
01/2012
1Nerve Growth Factors (Neurotrophins)IBA
01/2012
1Indicators and Reagents (Reagents)IBA
05/2011
1Ethanol (Ethyl Alcohol)IBA
05/2011
116- hydroxy- 9- oxo- 10,12,14- octadecatrienoic acidIBA
05/2011
1Monoclonal AntibodiesIBA
12/2010
1Cytidine DeaminaseIBA
11/2010
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2010

Therapy/Procedure

2Microvascular Decompression Surgery
01/2016 - 01/2016
1Tendon Transfer
04/2022
1Replantation
12/2020
1General Anesthesia
09/2020
1Drug Therapy (Chemotherapy)
01/2020
1Conservative Treatment
12/2018
1Transplantation
07/2011
1Therapeutics
07/2011
1Cell- and Tissue-Based Therapy (Cell Therapy)
07/2011
1Adrenalectomy
01/2010